Chemicals · Founded 1985 · www.privi.com · BSE 530117 · NSE PRIVISCL · ISIN INE959A01019
No Notes Added Yet
Business
Privi Speciality Chemicals Ltd. is a leading manufacturer and exporter of aroma chemicals in India. The company specializes in the production of various terpene-based aroma chemicals which are essential ingredients for the fragrance and flavor industry. Their products are primarily used in personal care (soaps, detergents, cosmetics), home care, food & beverages, and pharmaceutical applications. The core business model revolves around backward integration, R&D-led new product development, and serving global as well as domestic fragrance and flavor houses. The company makes money by manufacturing and selling these specialty aroma chemicals and intermediates to B2B customers globally.
Revenue Mix
Privi Speciality Chemicals primarily operates in the Aroma Chemicals segment. While explicit revenue percentages for sub-segments are not always publicly detailed, the vast majority of its revenue is derived from the sale of terpene-based aroma chemicals. The company has been expanding into related specialty intermediates, which form a smaller but growing part of its product portfolio, catering to various industrial applications beyond just fragrances and flavors.
Industry
The company operates within the broader Indian specialty chemicals sector, specifically carving a niche in aroma chemicals. The industry is characterized by increasing demand for differentiated and high-performance chemicals, driven by consumer preferences and technological advancements. Privi is positioned as one of the largest manufacturers of specific terpene-based aroma chemicals in India, competing with both domestic peers and international players. Its strong R&D capabilities and backward integration lend it a competitive edge in its niche, especially against smaller players.
MOAT
Backward Integration: Privi has a significant competitive advantage through its backward integration into key raw materials derived from turpentine oil. This ensures a more secure supply chain, better quality control, and often cost efficiency, reducing its dependence on external suppliers for critical inputs.
R&D and Process Expertise: The company possesses strong research and development capabilities, enabling it to develop new, complex, and high-value aroma chemicals and processes. This allows for product differentiation and caters to evolving customer demands.
Long-standing Customer Relationships: Privi has established long-term relationships with major global and domestic fragrance and flavor houses, which provides stable demand and insights into industry trends.
Scale in Niche: Being one of the largest Indian manufacturers in its specific aroma chemical product categories offers advantages in terms of production efficiency and market presence.
Growth Drivers
Increasing Demand for Fragrances & Flavors: Global and domestic demand for personal care, home care, food & beverages products continues to grow, driving consumption of aroma chemicals.
"China+1" Strategy: Global supply chain diversification, where companies look for alternatives to China, benefits Indian specialty chemical manufacturers like Privi due to their established capabilities and cost competitiveness.
New Product Development & Capacity Expansion: Continuous investment in R&D to launch new aroma chemicals and specialty intermediates, coupled with strategic capacity expansions, will drive future revenue.
Premiumization and Customization: Growing consumer preference for premium and customized fragrance and flavor profiles creates opportunities for higher-value specialty aroma chemicals.
Risks
Raw Material Price Volatility: Key raw materials like turpentine oil (derived from forest products) are subject to significant price fluctuations based on availability, demand, and forestry policies, which can impact profitability.
Environmental Regulations: The chemical industry is subject to stringent environmental laws. Any changes in regulations or non-compliance can lead to operational disruptions, increased costs, or penalties.
Intense Competition: The company faces competition from both domestic and international players, including larger, more diversified chemical companies, which can exert pressure on pricing and market share.
Foreign Exchange Fluctuations: As a significant exporter, Privi is exposed to currency exchange rate volatility, which can affect its realized revenues and profitability.
Capex Execution Risk: The successful and timely execution of planned capacity expansion projects is critical. Delays or cost overruns can impact projected growth and financial performance.
Management & Ownership
Privi Speciality Chemicals Ltd. is promoted by the Bhageria family. Mr. D.B. Bhageria, the Chairman & Managing Director, has been a driving force behind the company's growth and strategy. The promoter group holds a significant stake in the company (typically above 50%), demonstrating strong alignment with long-term performance. The management team generally comprises individuals with extensive experience in the chemical industry, particularly in specialty and aroma chemicals.
Outlook
Privi Speciality Chemicals is well-positioned to capitalize on the sustained growth in demand for aroma chemicals and the broader specialty chemicals sector, particularly benefiting from global supply chain shifts and increasing consumer discretionary spending. Its strong backward integration and R&D capabilities provide a foundation for competitive pricing and product innovation. However, the company faces inherent risks associated with raw material price volatility, stringent environmental regulations, and the capital-intensive nature of chemical manufacturing. Its ability to successfully execute expansion plans, manage input costs effectively, and continue innovating new products will be crucial for maintaining its growth trajectory and profitability in the competitive market.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 404 | 484 | 464 | 533 | 491 | 614 | 559 | 679 | 605 | 722 |
| Other Income | 6 | 8 | 3 | 4 | 2 | 15 | 9 | 0 | 7 | 4 |
| Total Income | 409 | 492 | 467 | 537 | 493 | 628 | 568 | 679 | 611 | 726 |
| Total Expenditure | 314 | 393 | 370 | 423 | 378 | 481 | 427 | 497 | 453 | 541 |
| Operating Profit | 96 | 99 | 97 | 115 | 115 | 147 | 141 | 182 | 158 | 184 |
| Interest | 24 | 25 | 22 | 22 | 22 | 23 | 24 | 21 | 19 | 18 |
| Depreciation | 32 | 30 | 32 | 32 | 32 | 35 | 36 | 36 | 36 | 36 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 39 | 44 | 43 | 61 | 61 | 90 | 81 | 125 | 104 | 130 |
| Provision for Tax | 10 | 12 | 11 | 16 | 16 | 26 | 24 | 35 | 29 | 36 |
| Profit After Tax | 29 | 32 | 31 | 45 | 44 | 64 | 58 | 90 | 75 | 94 |
| Adjustments | -0 | -1 | -0 | -0 | -0 | 3 | 4 | 4 | 3 | -0 |
| Profit After Adjustments | 29 | 31 | 31 | 45 | 44 | 67 | 62 | 94 | 78 | 94 |
| Adjusted Earnings Per Share | 7.4 | 7.9 | 8 | 11.4 | 11.4 | 17 | 15.9 | 24 | 20 | 24 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 597 | 1024 | 1341 | 1324 | 1277 | 1404 | 1608 | 1752 | 2101 | 2565 |
| Other Income | 10 | 16 | 6 | 26 | 20 | 32 | 21 | 26 | 21 | 20 |
| Total Income | 608 | 1040 | 1347 | 1350 | 1297 | 1436 | 1629 | 1779 | 2122 | 2584 |
| Total Expenditure | 525 | 894 | 1128 | 1104 | 1067 | 1209 | 1420 | 1424 | 1643 | 1918 |
| Operating Profit | 82 | 146 | 218 | 247 | 230 | 227 | 209 | 355 | 479 | 665 |
| Interest | 20 | 24 | 29 | 38 | 24 | 25 | 70 | 102 | 92 | 82 |
| Depreciation | 27 | 43 | 47 | 57 | 71 | 75 | 108 | 123 | 132 | 144 |
| Exceptional Income / Expenses | 0 | 0 | 9 | 40 | 23 | 5 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 36 | 79 | 152 | 193 | 158 | 133 | 31 | 130 | 255 | 440 |
| Provision for Tax | 8 | 26 | 57 | 47 | 41 | 35 | 10 | 34 | 70 | 124 |
| Profit After Tax | 27 | 53 | 94 | 146 | 117 | 97 | 21 | 95 | 185 | 317 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 2 | 11 |
| Profit After Adjustments | 27 | 53 | 94 | 146 | 117 | 97 | 22 | 95 | 187 | 328 |
| Adjusted Earnings Per Share | 7.2 | 14.2 | 24.1 | 37.4 | 29.9 | 24.9 | 5.7 | 24.3 | 47.9 | 83.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 20% | 14% | 10% | 0% |
| Operating Profit CAGR | 35% | 28% | 14% | 0% |
| PAT CAGR | 95% | 24% | 5% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 26% | 41% | 25% | 27% |
| ROE Average | 18% | 11% | 12% | 14% |
| ROCE Average | 17% | 12% | 12% | 13% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 444 | 488 | 576 | 612 | 723 | 812 | 829 | 924 | 1103 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 7 | 6 | 17 | 14 |
| Borrowings | 66 | 77 | 181 | 226 | 332 | 381 | 404 | 445 | 511 |
| Other Non-Current Liabilities | 25 | 31 | 39 | 33 | 32 | 47 | 51 | 61 | 58 |
| Total Current Liabilities | 403 | 457 | 630 | 513 | 454 | 929 | 1101 | 896 | 1103 |
| Total Liabilities | 939 | 1053 | 1426 | 1384 | 1540 | 2176 | 2391 | 2343 | 2791 |
| Fixed Assets | 388 | 435 | 498 | 598 | 598 | 704 | 1017 | 1034 | 1156 |
| Other Non-Current Assets | 67 | 77 | 127 | 58 | 242 | 419 | 172 | 166 | 271 |
| Total Current Assets | 485 | 541 | 801 | 728 | 700 | 1053 | 1202 | 1142 | 1363 |
| Total Assets | 939 | 1053 | 1426 | 1384 | 1540 | 2176 | 2391 | 2343 | 2791 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 12 | 16 | 85 | 15 | 33 | 20 | 24 |
| Cash Flow from Operating Activities | 17 | 107 | 21 | 216 | 149 | 5 | 49 | 354 | 281 |
| Cash Flow from Investing Activities | -67 | -81 | -139 | -176 | -242 | -320 | -133 | -180 | -294 |
| Cash Flow from Financing Activities | -89 | -20 | 122 | 28 | 23 | 333 | 72 | -171 | 39 |
| Net Cash Inflow / Outflow | -140 | 5 | 4 | 68 | -69 | 17 | -12 | 4 | 26 |
| Closing Cash & Cash Equivalent | 7 | 12 | 16 | 85 | 15 | 33 | 20 | 24 | 50 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 7.21 | 14.19 | 24.13 | 37.38 | 29.93 | 24.93 | 5.69 | 24.3 | 47.87 |
| CEPS(Rs) | 14.34 | 25.7 | 36.12 | 51.92 | 48.1 | 44.04 | 33.22 | 56.02 | 81.02 |
| DPS(Rs) | 1 | 1.5 | 2.5 | 1.5 | 2 | 2 | 0 | 2 | 5 |
| Book NAV/Share(Rs) | 117.7 | 129.47 | 147.37 | 156.68 | 184.96 | 207.8 | 212.24 | 236.64 | 282.48 |
| Core EBITDA Margin(%) | 11.31 | 12.48 | 15.68 | 16.63 | 16.42 | 13.88 | 11.67 | 18.75 | 21.8 |
| EBIT Margin(%) | 8.72 | 9.86 | 13.31 | 17.36 | 14.23 | 11.25 | 6.26 | 13.21 | 16.51 |
| Pre Tax Margin(%) | 5.59 | 7.57 | 11.17 | 14.52 | 12.38 | 9.45 | 1.93 | 7.41 | 12.11 |
| PAT Margin (%) | 4.26 | 5.11 | 6.95 | 11.01 | 9.15 | 6.93 | 1.32 | 5.45 | 8.79 |
| Cash Profit Margin (%) | 8.48 | 9.26 | 10.4 | 15.29 | 14.7 | 12.25 | 8.07 | 12.49 | 15.06 |
| ROA(%) | 2.89 | 5.36 | 7.6 | 10.4 | 8 | 5.24 | 0.93 | 4.03 | 7.2 |
| ROE(%) | 6.13 | 11.48 | 17.74 | 24.59 | 17.52 | 12.69 | 2.59 | 10.88 | 18.22 |
| ROCE(%) | 7.25 | 13 | 19.17 | 21.11 | 15.36 | 10.64 | 5.58 | 12.22 | 16.88 |
| Receivable days | 99.76 | 70.7 | 75.49 | 77.01 | 66.81 | 65.48 | 63.62 | 66.98 | 64.42 |
| Inventory Days | 141.22 | 83.95 | 80.47 | 95.36 | 95.83 | 124.57 | 160.66 | 151.93 | 125.75 |
| Payable days | 115.18 | 76.27 | 81.89 | 84.18 | 78.85 | 107.03 | 116.54 | 93.78 | 78.7 |
| PER(x) | 75.96 | 26.57 | 19.21 | 11.17 | 28.34 | 75.35 | 184.75 | 40.78 | 35.66 |
| Price/Book(x) | 4.65 | 2.91 | 3.14 | 2.66 | 4.58 | 9.04 | 4.95 | 4.19 | 6.04 |
| Dividend Yield(%) | 0.18 | 0.4 | 0.54 | 0.36 | 0.24 | 0.11 | 0 | 0.2 | 0.29 |
| EV/Net Sales(x) | 3.94 | 1.68 | 1.7 | 1.54 | 3 | 5.85 | 3.19 | 2.75 | 3.68 |
| EV/Core EBITDA(x) | 28.57 | 11.8 | 10.43 | 8.28 | 16.64 | 36.09 | 24.56 | 13.58 | 16.14 |
| Net Sales Growth(%) | 0 | 71.49 | 30.92 | -1.26 | -3.59 | 9.96 | 14.54 | 8.98 | 19.91 |
| EBIT Growth(%) | 0 | 85.41 | 75.49 | 27.48 | -20.98 | -13.11 | -36.35 | 130.04 | 49.9 |
| PAT Growth(%) | 0 | 96.69 | 76.65 | 54.95 | -19.95 | -16.7 | -78.15 | 348.49 | 93.6 |
| EPS Growth(%) | 0 | 96.69 | 70.08 | 54.95 | -19.95 | -16.7 | -77.19 | 327.22 | 97.03 |
| Debt/Equity(x) | 0.72 | 0.67 | 0.85 | 0.82 | 0.73 | 1.12 | 1.27 | 1.06 | 1 |
| Current Ratio(x) | 1.2 | 1.18 | 1.27 | 1.42 | 1.54 | 1.13 | 1.09 | 1.27 | 1.24 |
| Quick Ratio(x) | 0.59 | 0.67 | 0.69 | 0.78 | 0.79 | 0.47 | 0.37 | 0.54 | 0.52 |
| Interest Cover(x) | 2.78 | 4.3 | 6.22 | 6.13 | 7.68 | 6.25 | 1.45 | 2.28 | 3.76 |
| Total Debt/Mcap(x) | 0.16 | 0.23 | 0.27 | 0.31 | 0.16 | 0.12 | 0.26 | 0.25 | 0.17 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 69.89 | 69.89 | 60.6 | 60.6 |
| FII | 0.96 | 0.62 | 0.48 | 0.43 | 0.48 | 0.4 | 1.47 | 1.33 | 1.64 | 1.38 |
| DII | 3.4 | 3.37 | 2.84 | 2.5 | 2.09 | 1.95 | 3.9 | 4.55 | 10.24 | 10.67 |
| Public | 21.6 | 21.95 | 22.63 | 23.03 | 23.38 | 23.61 | 24.74 | 24.23 | 27.52 | 27.36 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 | 2.73 | 2.73 | 2.37 | 2.37 |
| FII | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.06 | 0.05 | 0.06 | 0.05 |
| DII | 0.13 | 0.13 | 0.11 | 0.1 | 0.08 | 0.08 | 0.15 | 0.18 | 0.4 | 0.42 |
| Public | 0.84 | 0.86 | 0.88 | 0.9 | 0.91 | 0.92 | 0.97 | 0.95 | 1.07 | 1.07 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +20% | +14% | +10% | — |
| Operating Profit CAGR | +35% | +28% | +14% | — |
| PAT CAGR | +95% | +24% | +5% | — |
| Share Price CAGR | +26% | +41% | +25% | +27% |
| ROE Average | +18% | +11% | +12% | +14% |
| ROCE Average | +17% | +12% | +12% | +13% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 74.05 | 69.89 | 69.89 | 60.6 | 60.6 |
| FII | 0.96 | 0.62 | 0.48 | 0.43 | 0.48 | 0.4 | 1.47 | 1.33 | 1.64 | 1.38 |
| DII | 3.4 | 3.37 | 2.84 | 2.5 | 2.09 | 1.95 | 3.9 | 4.55 | 10.24 | 10.67 |
| Public | 25.95 | 25.95 | 25.95 | 25.95 | 25.95 | 25.95 | 30.11 | 30.11 | 39.4 | 39.4 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 | 2.73 | 2.73 | 2.37 | 2.37 |
| FII | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.06 | 0.05 | 0.06 | 0.05 |
| DII | 0.13 | 0.13 | 0.11 | 0.1 | 0.08 | 0.08 | 0.15 | 0.18 | 0.4 | 0.42 |
| Public | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.18 | 1.18 | 1.54 | 1.54 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.